This analysis explores regenerative medicine's potential in treating gastrointestinal leaks and fistulas, highlighting its efficacy and limitations.
Gastrointestinal (GI) wall defects, also known as transmural defects, comprise three distinct entities: perforation, leak, and fistula [1]. While perforation may occur spontaneously (e.g. Boerhaave syndrome), be induced by foreign bodies, or result from endoscopic manipulation, leaks and fistulas are typically related to surgery or radiotherapy. A GI leak, for example, is characterized by the disruption of a surgical anastomosis, allowing contents to escape into the surrounding space. A fistula, in contrast, implies the presence of a tract connecting the GI lumen with the skin or a contiguous organ (e.g. a rectovaginal fistula). In chronic fistulas, the tract is typically lined with epithelium.
No takes yet. Share an insight, caveat, or question.
Fauze Maluf‐Filho (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: